Benicar (olmesartan) is a blood pressure drug that has been linked to chronic diarrhea, a side effect of sprue-like enteropathy. Over 1,800 lawsuits have already been filed by people who suffered from diarrhea and developed debilitating complications.
What You Can Do & How We Can Help
The Schmidt Firm, PLLC is currently accepting Benicar induced injury cases in all 50 states. If you or somebody you know was injured by chronic diarrhea, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call us toll-free 24 hours a day at (866) 920-0753.
Benicar (olmesartan), an anti-hypertensive medication created by Daiichi Sankyo Inc., has been linked to an increased risk of sprue-like enteropathy. This serious intestinal disease causes chronic diarrhea with frequent, watery bowel movements.
The symptoms of enteropathy typically do not appear for months or even years after a patient starts taking Benicar. No one knows exactly what causes diarrhea from Benicar, but it could be a localized hypersensitivity reaction or an immune response.
Celiac Disease Misdiagnosis
Chronic diarrhea is a hallmark symptom of Celiac disease (also known as “celiac sprue”), a disease caused by gluten intolerance. Many people on Benicar who developed sprue-like enteropathy were misdiagnosed with Celiac disease because the symptoms and intestinal biopsies are nearly identical. Unlike Celiac disease, Benicar-induced diarrhea can only be cured by discontinuing the medication.
The U.S. Food and Drug Administration (FDA) update the warnings for Benicar in July 2013, after reviewing their database of adverse events and finding 23 cases of sprue-like enteropathy. They warned about “clear evidence” linking Benicar and chronic diarrhea.
FDA recommendation for patients:
“Contact your health care professional right away if you take an olmesartan-containing product and experience severe diarrhea, diarrhea that does not go away, or significant weight loss.”
The FDA has also issued warnings about a lack of risk information in some advertisements for Benicar. Warning letters were issued to Daiichi Sankyo in 2006 and again in 2013. In both cases, the FDA cited “false or misleading” statements. In one case, Benicar was advertised as the “superior ARB.” However, the FDA says Benicar is the only anti-hypertensive drug in the ARB class that has been linked to chronic diarrhea.
Case Report Links Benicar and Diarrhea
March 2014 — Case Reports in Gastrointestinal Medicine publishes a report of a 52 year-old woman who used Benicar (20-mg/day) for three years and developed chronic diarrhea.
She suffered from 20 bowel movements per day for one year and had a 45-pound weight-loss within six months. When she visited the hospital, she was diagnosed with a colon perforation. Other symptoms included nausea, occasional vomiting, bloating, and severe abdominal pain. After discontinuing Benicar, her symptoms improved in one month.
Complications of Chronic Diarrhea
- Intestinal damage (villous atrophy)
- Decreased ability to digest food
- Vitamin and electrolyte (mineral) imbalances
- Severe weight-loss
- Kidney damage or failure
- And more
Do I have a Benicar Lawsuit?
The Schmidt Firm, PLLC is currently accepting Benicar induced injury cases in all 50 states. If you or somebody you know was injured by sprue-like enteropathy, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call us toll-free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.